290 related articles for article (PubMed ID: 29754112)
21. MR1: a multi-faceted metabolite sensor for T cell activation.
McWilliam HE; Villadangos JA
Curr Opin Immunol; 2020 Jun; 64():124-129. PubMed ID: 32604057
[TBL] [Abstract][Full Text] [Related]
22. A specialized tyrosine-based endocytosis signal in MR1 controls antigen presentation to MAIT cells.
Lim HJ; Wubben JM; Garcia CP; Cruz-Gomez S; Deng J; Mak JYW; Hachani A; Anderson RJ; Painter GF; Goyette J; Amarasinghe SL; Ritchie ME; Roquilly A; Fairlie DP; Gaus K; Rossjohn J; Villadangos JA; McWilliam HEG
J Cell Biol; 2022 Dec; 221(12):. PubMed ID: 36129434
[TBL] [Abstract][Full Text] [Related]
23. The Diverse Family of MR1-Restricted T Cells.
Gherardin NA; McCluskey J; Rossjohn J; Godfrey DI
J Immunol; 2018 Nov; 201(10):2862-2871. PubMed ID: 30397170
[TBL] [Abstract][Full Text] [Related]
24. Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity.
Dias J; Sobkowiak MJ; Sandberg JK; Leeansyah E
J Leukoc Biol; 2016 Jul; 100(1):233-40. PubMed ID: 27034405
[TBL] [Abstract][Full Text] [Related]
25. Biased MAIT TCR Usage Poised for Limited Antigen Diversity?
Souter MNT; Eckle SBG
Front Immunol; 2020; 11():1845. PubMed ID: 33013835
[TBL] [Abstract][Full Text] [Related]
26. Production of MR1 Tetramers Loaded with Microbial Ligands.
Ladd NA; Froyd CA; Adams EJ
Methods Mol Biol; 2020; 2098():191-207. PubMed ID: 31792824
[TBL] [Abstract][Full Text] [Related]
27. Alternative splicing of MR1 regulates antigen presentation to MAIT cells.
Narayanan GA; Nellore A; Tran J; Worley AH; Meermeier EW; Karamooz E; Huber ME; Kurapova R; Tafesse FG; Harriff MJ; Lewinsohn DM
Sci Rep; 2020 Sep; 10(1):15429. PubMed ID: 32963314
[TBL] [Abstract][Full Text] [Related]
28. Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.
McWilliam HEG; Mak JYW; Awad W; Zorkau M; Cruz-Gomez S; Lim HJ; Yan Y; Wormald S; Dagley LF; Eckle SBG; Corbett AJ; Liu H; Li S; Reddiex SJJ; Mintern JD; Liu L; McCluskey J; Rossjohn J; Fairlie DP; Villadangos JA
Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24974-24985. PubMed ID: 32958637
[TBL] [Abstract][Full Text] [Related]
29. CD1, MR1, NKT, and MAIT: evolution and origins of non-peptidic antigen recognition by T lymphocytes.
Zajonc DM; Flajnik MF
Immunogenetics; 2016 Aug; 68(8):489-90. PubMed ID: 27480412
[No Abstract] [Full Text] [Related]
30. Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.
Laugel B; Lloyd A; Meermeier EW; Crowther MD; Connor TR; Dolton G; Miles JJ; Burrows SR; Gold MC; Lewinsohn DM; Sewell AK
J Immunol; 2016 Aug; 197(3):971-82. PubMed ID: 27307560
[TBL] [Abstract][Full Text] [Related]
31. Virus-Mediated Suppression of the Antigen Presentation Molecule MR1.
McSharry BP; Samer C; McWilliam HEG; Ashley CL; Yee MB; Steain M; Liu L; Fairlie DP; Kinchington PR; McCluskey J; Abendroth A; Villadangos JA; Rossjohn J; Slobedman B
Cell Rep; 2020 Mar; 30(9):2948-2962.e4. PubMed ID: 32130899
[TBL] [Abstract][Full Text] [Related]
32. MR1 presents microbial vitamin B metabolites to MAIT cells.
Kjer-Nielsen L; Patel O; Corbett AJ; Le Nours J; Meehan B; Liu L; Bhati M; Chen Z; Kostenko L; Reantragoon R; Williamson NA; Purcell AW; Dudek NL; McConville MJ; O'Hair RA; Khairallah GN; Godfrey DI; Fairlie DP; Rossjohn J; McCluskey J
Nature; 2012 Nov; 491(7426):717-23. PubMed ID: 23051753
[TBL] [Abstract][Full Text] [Related]
33. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
[TBL] [Abstract][Full Text] [Related]
34. Covering All the Bases: Complementary MR1 Antigen Presentation Pathways Sample Diverse Antigens and Intracellular Compartments.
Kulicke C; Karamooz E; Lewinsohn D; Harriff M
Front Immunol; 2020; 11():2034. PubMed ID: 32983150
[TBL] [Abstract][Full Text] [Related]
35. The effect of MR1 ligand glyco-analogues on mucosal-associated invariant T (MAIT) cell activation.
Braganza CD; Shibata K; Fujiwara A; Motozono C; Sonoda KH; Yamasaki S; Stocker BL; Timmer MSM
Org Biomol Chem; 2019 Oct; 17(40):8992-9000. PubMed ID: 31497838
[TBL] [Abstract][Full Text] [Related]
36. Recognition of the antigen-presenting molecule MR1 by a Vδ3
Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
[TBL] [Abstract][Full Text] [Related]
37. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
Zumwalde NA; Haag JD; Gould MN; Gumperz JE
Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
[TBL] [Abstract][Full Text] [Related]
38. The biology and functional importance of MAIT cells.
Godfrey DI; Koay HF; McCluskey J; Gherardin NA
Nat Immunol; 2019 Sep; 20(9):1110-1128. PubMed ID: 31406380
[TBL] [Abstract][Full Text] [Related]
39. Ligand-dependent downregulation of MR1 cell surface expression.
Salio M; Awad W; Veerapen N; Gonzalez-Lopez C; Kulicke C; Waithe D; Martens AWJ; Lewinsohn DM; Hobrath JV; Cox LR; Rossjohn J; Besra GS; Cerundolo V
Proc Natl Acad Sci U S A; 2020 May; 117(19):10465-10475. PubMed ID: 32341160
[TBL] [Abstract][Full Text] [Related]
40. MR1-dependent antigen presentation.
Karamooz E; Harriff MJ; Lewinsohn DM
Semin Cell Dev Biol; 2018 Dec; 84():58-64. PubMed ID: 30449535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
